Article Information
PubMed
Published By
History
- Received May 5, 2022
- Revision received September 9, 2022
- Accepted October 2, 2022
- Published online November 9, 2022.
Copyright & Usage
Copyright © 2022 Paul et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Sangita Paul1,2,
- Saman Fatihi1,2,
- Srishti Sharma1,2,
- Rintu Kutum1,
- Raymond Fields3,
- Harish C. Pant4,
- Lipi Thukral1,2 and
- Binukumar BK1,2
- 1Council of Scientific and Industrial Research–Institute of Genomics and Integrative Biology, New Delhi 110007, India
- 2Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India
- 3Viral Production Core Facility, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892
- 4Neuronal Cytoskeletal Protein Regulation Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892
- Correspondence should be addressed to Binukumar BK at binukumarbk{at}gmail.com.
Author contributions
Author contributions: B.B.K. designed research; S.P., S.F., S.S., R.K., R.F., L.T., and B.B.K. performed research; S.P., H.C.P., and B.B.K. analyzed data; S.P. and B.B.K. wrote the paper.
Disclosures
The authors declare no competing financial interests.
The authors received funding support from the Council of Scientific and Industrial Research (CSIR; Grants MLP2001 and MLP2008) and the Science and Engineering Research Board of India (Grant GAP0168); a senior research fellowship to S.P. from CSIR; and a junior research fellowship to S.S. from the University Grants Commission.
Funding
Council of Scientific and Industrial Research, India (CSIR)
MLP2001 and 2008SERB India
GAP0168
Other Version
- You are viewing the most recent version of this article.
- previous version (November 09, 2022).
Article usage
In this issue
Cyclin-Dependent Kinase 5 Regulates cPLA2 Activity and Neuroinflammation in Parkinson’s Disease
